{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T10:10:02Z","timestamp":1755857402158,"version":"3.44.0"},"reference-count":9,"publisher":"SMC Media","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>A patient with antisynthetase syndrome with pulmonary and muscular involvement was treated with immunosuppressive agents without corticosteroids. Rituximab was added to mycophenolate mofetil therapy with improvement in lung functional and imaging findings and normalization of creatine kinase levels.<\/jats:p>","DOI":"10.12890\/2022_003324","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T04:00:30Z","timestamp":1658116830000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids"],"prefix":"10.12890","volume":"9","author":[{"given":"Agnieszka Ewa","family":"Sieradzka","sequence":"additional","affiliation":[{"name":"Private Practice, Riva San Vitale, Ticino, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Naccini","sequence":"additional","affiliation":[{"name":"Pneumology Service, Ospedale Beata Vergine, Mendrisio, Ticino, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Fontana","sequence":"additional","affiliation":[{"name":"Allergology and Clinical Immunology Service, Ospedale Beata Vergine, Mendrisio, Ticino, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10397","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"10.12890\/2022_003324_ref1","doi-asserted-by":"crossref","unstructured":"<li>Barba T, Fort R, Cottin V, Provencher S, Dureu I, Jardel S, et al. Treatment of idiopathic inflammatory myositis associated interstitial lung disease: a systematic review and meta-analysis. <em>Autoimmun Rev<\/em> 2019;<strong>18<\/strong>(2):113\u2013122.<\/li>","DOI":"10.1016\/j.autrev.2018.07.013"},{"key":"10.12890\/2022_003324_ref2","doi-asserted-by":"crossref","unstructured":"<li>Witt LJ, Curran JJ, Strek ME. The diagnosis and treatment of antisynthetase syndrome. <em>Clin Pulm Med<\/em> 2016;<strong>23<\/strong>(5):218\u2013226.<\/li>","DOI":"10.1097\/CPM.0000000000000171"},{"key":"10.12890\/2022_003324_ref3","doi-asserted-by":"crossref","unstructured":"<li>Marco JL, Collins BF. Clinical manifestations and treatment of antisynthetase syndrome. <em>Best Pract Res Clin Rheumatol<\/em> 2020;<strong>34<\/strong>(4):101503.<\/li>","DOI":"10.1016\/j.berh.2020.101503"},{"key":"10.12890\/2022_003324_ref4","doi-asserted-by":"crossref","unstructured":"<li>Joffe MM, Love LA, Leff RL, Fraser DD, Targoff IN, Hicks JE, et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine and methotrexate and a comparison of their efficacy. <em>Am J Med<\/em> 1993;<strong>94<\/strong>:379\u2013387.<\/li>","DOI":"10.1016\/0002-9343(93)90148-I"},{"key":"10.12890\/2022_003324_ref5","unstructured":"<li>Labirua-Iturburu A, Selva-O'Callaghan A, Mart\u00ednez-Gomez X, Trallero-Araguas E, Labrador-Horrillo M, Vilardell-Tarres M. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. <em>Clin Exp Rheumatol<\/em> 2013;<strong>31<\/strong>(3):436\u2013439.<\/li>"},{"key":"10.12890\/2022_003324_ref6","doi-asserted-by":"crossref","unstructured":"<li>Andersson H, Sem M, Lund MB, Aal\u00f8kken TM, G\u00fcnther A, Walle-Hansen R, et al. Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease. <em>Rheumatology (Oxford)<\/em> 2015;<strong>54<\/strong>(8):1420\u20131428.<\/li>","DOI":"10.1093\/rheumatology\/kev004"},{"key":"10.12890\/2022_003324_ref7","doi-asserted-by":"crossref","unstructured":"<li>Bauhammer J, Blank N, Max R, Lorenz H-M, Wagner U, Krause D, et al. Rituximab in the treatment of Jo1 antibody associated antisynthetase syndrome: anti-Ro52 positivity as a marker for severity and treatment response. <em>J Rheumatol<\/em> 2016;<strong>43<\/strong>(8):1566\u20131574.<\/li>","DOI":"10.3899\/jrheum.150844"},{"key":"10.12890\/2022_003324_ref8","doi-asserted-by":"crossref","unstructured":"<li>Marie I, Dominique S, Janvresse A, Levesque H, Menard JF. Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome. <em>Resp Med<\/em> 2012;<strong>106<\/strong>:581\u2013587.<\/li>","DOI":"10.1016\/j.rmed.2012.01.001"},{"key":"10.12890\/2022_003324_ref9","doi-asserted-by":"crossref","unstructured":"<li>Doyle TJ, Dhillon N, Madan R, Cabral F, Fletcher EA, Koontz DC, et al. Rituximab in the treatment of interstitial lung disease associated with antisynthetase syndrome: a multi-center retrospective case review.<em> J Rheumatol<\/em> 2018;<strong>45<\/strong>(6):841\u2013850.<\/li>","DOI":"10.3899\/jrheum.170541"}],"container-title":["European Journal of Case Reports in Internal Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/3324\/3172","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/3324\/3173","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/3324\/3173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T09:31:34Z","timestamp":1755855094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/view\/3324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":9,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.12890\/2022_003324","relation":{"has-manifestation":[{"id-type":"other","id":"1-88-3324-g3172","asserted-by":"subject"},{"id-type":"other","id":"1-88-3324-g3173","asserted-by":"subject"}],"is-part-of":[{"id-type":"other","id":"1-88","asserted-by":"subject"}]},"ISSN":["2284-2594"],"issn-type":[{"type":"electronic","value":"2284-2594"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"article-number":"7"}}